Consistently, the levels of PINP, Colla1, Runx2, and OCN were increased in BMSCs under OM, and this phenomenon was reversed by the miR-133a-3p inhibitor (Fig. 2C-D). This evidence concerns the gene RUNX2 and ocular melanoma.